Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2011
05/17/2011US7943615 Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
05/17/2011US7943609 Chiral fused [1,2]imidazo[4,5-C] ring compounds
05/17/2011US7943608 Diazepinoes
05/17/2011CA2514267C Malonamide derivatives as gamma-secretase inhibitors
05/12/2011WO2011057145A2 Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same
05/12/2011WO2011056630A2 Small molecule inhibitors of hepatitis c virus
05/12/2011WO2011055911A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/12/2011WO2011055215A2 Novel kinase modulators
05/12/2011WO2011055115A1 Akt / pkb inhibitors
05/12/2011WO2011054922A1 Salts of fused pyrazine compounds, useful for the treatment of degenerative and inflammatory diseases.
05/12/2011WO2011054845A1 Benzodiazepine bromodomain inhibitor
05/12/2011WO2011054844A1 Condensed azepine derivatives as bromodomain inhibitors
05/12/2011WO2011054553A1 Benzodiazepine bromodomain inhibitor
05/12/2011WO2011023783A3 Method for preparing silica particles containing a phthalocyanine derivative, said particles, and uses thereof
05/12/2011WO2011005909A3 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
05/12/2011WO2010151735A3 4h - pyrido [ 1, 2 - a] pyrimidin - 4 - one derivatives as pi3 k inhibitors
05/12/2011WO2010147898A3 Small molecule inhibitors of spleen tyrosine kinase (syk)
05/12/2011US20110112464 Meso-substituted porphyrins
05/12/2011US20110112287 Carbon nanoparticles, which are covalently bound via a bridge molecule to a target molecule, and a method for the production thereof
05/12/2011US20110112097 Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof
05/12/2011US20110112083 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
05/12/2011US20110112079 Phosphodiesterase inhibitors
05/12/2011US20110112078 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
05/12/2011US20110112062 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1
05/12/2011US20110112052 Spiro-oxindole mdm2 antagonists
05/12/2011US20110112051 Dipeptidyl Peptidase-IV Inhibitors
05/12/2011US20110110957 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
05/12/2011US20110110914 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
05/12/2011CA2779574A1 Novel kinase modulators
05/12/2011CA2779423A1 Benzodiazepine bromodomain inhibitor
05/12/2011CA2779355A1 Benzodiazepine bromodomain inhibitor
05/11/2011EP2319621A2 Base stable ionic liquids
05/11/2011EP2318414A2 Imidazo [1,2-a] pyrimidine derivatives, process for their preparation, use as medicaments, pharmaceutical compositions and use as met inhibitors
05/11/2011EP2318413A1 Pyrrolobenzodiazepines
05/11/2011EP2318412A1 Protein kinase inhibitors
05/11/2011EP2318411A2 Crystalline salts of sitagliptin
05/11/2011EP2318410A2 New small-molecule pde-10 inhibitors
05/11/2011EP2318401A2 Azaindole inhibitors of iap
05/11/2011EP2318394A1 Novel phenylimidazole derivatives as pde10a enzyme inhibitors
05/11/2011EP2318387A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists
05/11/2011EP2318378A2 Quinazoline derivatives
05/11/2011EP2094703B1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes
05/11/2011EP1606254B1 2,4,6-phenyl substituted cyclic ketoenols
05/11/2011EP1411929B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
05/11/2011CN102056929A Halogen compound, polycyclic compound and organic electroluminescent element using the polycyclic compound
05/11/2011CN102056928A Method for producing bicyclic guanidines by use of a cyclic urea
05/11/2011CN102056927A Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
05/11/2011CN102056917A Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
05/11/2011CN102056911A Halogen compound, polycyclic compound, and organic electroluminescence element comprising the polycyclic compound
05/11/2011CN102056899A Polycyclic compound and organic electroluminescent device using the same
05/11/2011CN102050825A Method for preparing pemetrexed disodium 2.5 water crystal
05/11/2011CN102050824A Piperazinoltriazole derivatives
05/11/2011CN102050776A 5-substituted methylpyrrolidine-2, 4-diketone compound and use thereof
05/11/2011CN102050722A 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
05/11/2011CN101619064B Synthesis and process method for novel polynitrogen heterocycle pharmaceutical intermediates
05/11/2011CN101602747B Preparation and application of 3, 7-disubstituted-N-hexyl phenothiazine derivative
05/11/2011CN101560211B Preparation for 1,2,4-triazolo[1,5-a]pyrimidine-2-ethyl thioether monosubstituted derivative and application thereof
05/11/2011CN101177370B Method for synthesizing heteroaromatic carboxylate and heterocyclic amino acid
05/11/2011CN101103032B Bicyclic pyrrole derivatives
05/11/2011CN101052640B Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
05/10/2011US7939662 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
05/10/2011US7939656 Geometric synthesis of porphyrin rods
05/10/2011US7939533 Dual NK1/NK3 receptor antagonists
05/10/2011US7939521 2-arylpropionic acid derivatives and pharmaceutical compositions containing them
05/10/2011CA2519063C Immunomodulating heterocyclic compounds
05/10/2011CA2501322C Quinolinyl-pyrrolopyrazoles
05/05/2011WO2011052805A1 Nitrogen-containing aromatic compounds and metal complexes
05/05/2011WO2011052759A1 Novel nitroxyl radical compound and process for production thereof
05/05/2011WO2011052535A1 Fullerene derivative
05/05/2011WO2011051858A1 Imidazole derivatives as casein kinase inhibitors
05/05/2011WO2011051478A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/05/2011WO2011051342A1 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
05/05/2011WO2010110685A3 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
05/05/2011US20110105746 Method of making porphyrins
05/05/2011US20110105745 Compositions and methods of making a photoactive agent
05/05/2011US20110105557 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
05/05/2011US20110105548 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
05/05/2011US20110105515 Targeting the oncoprotein nucleophosmin
05/05/2011US20110105514 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
05/05/2011US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof
05/05/2011US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors
05/05/2011US20110105477 Compositions and methods relating to hiv protease inhibition
05/05/2011US20110105476 Substituted 7,8-dihydro-1hpyrimido[4,5-b]diazepin-4-amines are novel kinase inhibitors
05/05/2011US20110105474 Heterocyclic derivatives as hdac inhibitors
05/05/2011US20110105457 Heterocyclic compound having inhibitory activity on pi3k
05/05/2011US20110104287 Fenoldopam formulations and pro-drug derivatives
05/05/2011US20110104043 Instrument and process for nanoparticles production in continuous flow mode
05/05/2011US20110101319 Organic electroluminescent device
05/05/2011US20110101312 Deuterated compounds for electronic applications
05/05/2011CA2779073A1 Novel oxime derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/05/2011CA2778949A1 Imidazo[1,2-b]pyridazine derivatives and their use as pde10 inhibitors
05/05/2011CA2778615A1 Methods of synthesis and purification of heteroaryl compounds
05/05/2011CA2777632A1 Imidazole derivatives as casein kinase inhibitors
05/04/2011EP2316836A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acetylcholine receptors
05/04/2011EP2316835A1 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
05/04/2011EP2315751A1 Alkynyl alcohols as kinase inhibitors
05/04/2011EP2315521A1 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h 4 receptor
05/04/2011EP1802372B1 Cgrp receptor antagonists
05/04/2011EP1317448B2 Pyrazole compounds useful as protein kinase inhibitors
05/04/2011CN1968949B Proline derivatives and their use as dipeptidyl peptidase IV inhibitors